Enovis (ENOV) Net Income (2010 - 2026)
Enovis' (ENOV) quarterly Net Income came in at -$39000.0 in Q2 2026, up 68.8% year-on-year from -$23104.3 in Q2 2025, and up 97.64% on a QoQ basis from -$1.7 million in Q4 2025.
Enovis (ENOV) Net Income (2010 - 2026) Analysis & Trends
Enovis (ENOV) has 17 years of Net Income data on file, last reported at -$39000.0 in Q2 2026.
- On a quarterly basis, Net Income rose 68.8% year-over-year to -$39000.0 in Q2 2026; TTM through Apr 2026 was -$1.8 million, a 173.63% decrease from a year earlier, with the FY2025 full-year figure at -$1.9 million, down 173.39% from the prior year.
- Net Income for Q2 2026 stood at -$39000.0, up from -$1.7 million in the prior quarter.
- Over the last five years, Net Income for ENOV reached as high as $54.4 million in Q2 2022 and fell as low as -$43.7 million in Q3 2022.
- Historically, Net Income has averaged $3.0 million across 5 years, with a median of -$39500.0 in 2025.
- Across the five-year window, Net Income surged 3450.0% in 2024 and slumped 487.56% in 2025, its largest moves.
- Year by year, Net Income stood at $16.3 million in 2022, then slumped by 99.93% to $12000.0 in 2023, then jumped by 3450.0% to $426000.0 in 2024, then slumped by 487.56% to -$1.7 million in 2025, then surged by 97.64% to -$39000.0 in 2026.
- Per Business Quant data, the three most recent Net Income figures were -$39000.0 in Q2 2026, -$1.7 million in Q4 2025, and -$40000.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 170.93 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Enovis | 1.50 Bn | 1.47 Bn | 365.49 Mn | -39,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -39,000.00 |
| Dec 31, 2025 | -1.65 Mn |
| Oct 3, 2025 | -40,000.00 |
| Jul 4, 2025 | -93,000.00 |
| Apr 4, 2025 | -125,000.00 |
| Dec 31, 2024 | 426,000.00 |
| Sep 27, 2024 | 2.24 Mn |
| Jun 28, 2024 | -68,000.00 |
| Dec 31, 2023 | 12,000.00 |
| Sep 29, 2023 | 16.61 Mn |
| Jun 30, 2023 | 4.80 Mn |
| Mar 31, 2023 | -312,000.00 |
| Dec 31, 2022 | 16.27 Mn |
| Sep 30, 2022 | -527,000.00 |
| Jul 1, 2022 | -43.67 Mn |
| Apr 1, 2022 | 54.36 Mn |
| Dec 31, 2021 | 14.17 Mn |
| Oct 1, 2021 | 40.44 Mn |
| Jul 2, 2021 | 71.83 Mn |
| Apr 2, 2021 | 52.09 Mn |